The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	25.49B
Revenue (ttm)	15.45B
Net Income (ttm)	3.36B
Shares Out	1.97B
EPS (ttm)	1.85
PE Ratio	6.99
Forward PE	7.99
Dividend	0.62 (4.77%)
Ex-Dividend Date	Sep 25, 2025

Volume	6,303,500
Average Volume	11,189,626
Open	12.80
Previous Close	12.84
Day's Range	12.66 - 12.94
52-Week Range	10.58 - 17.98
Beta	0.12
RSI	52.43
Earnings Date	Nov 28, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY